Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 1999

View Archived Issues

Vancomycin-tolerant S. pneumoniae detected and analyzed

Delta-opioid receptor activation as preconditioning, similar to natural hibernation

Zanamivir shows promise in influenza prevention

Mallinckrodt and SmithKline Beecham sign copromotion agreement for ADHD drug

Patient enrollment completed in study of shortened Targis treatment for BPH

Digital Gene Technologies and Recordati reach milestone in atherosclerosis agreement

Connetics enters licensing and development agreement with Paladin for ConXn

AxyS Pharmaceuticals forms new subsidiary

Company Profile: Maret

BTG acquires novel technology for treatment of HIV

Clinical trials commence for two new Eisai compounds

Allergan ciclosporin NDA up for review this month by advisory committee

New orally bioavailable salt of ET antagonist prepared by SmithKline Beecham

Antitumor and antibacterial compound isolated from cultures of Streptomyces at Kyowa Hakko

Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal

Human Genome Sciences discovery may lead to novel immunotherapies and vaccines

P2X7 receptor antagonists described in recent patent literature

Aromatic hydrazones from Uniroyal with anti-HIV-1 activity encompassing mutant strains

Anti-CD154 antibody facilitates islet allograft survival in highly relevant preclinical model

Potential of cerebrocrast in diabetes suggested by animal data

INO-5042: new agent for venous insufficiency proves effective in various animal models

Orphan Medical, Pierre Fabre sign letter of intent to license Busulfex

CAT gets U.K. approval to begin phase II trials of novel glaucoma treatment

Johns Hopkins team identifies unusually promising new treatment for ALS

E.U.-wide approval obtained for Ziagen

Inhibitors of P. carinii and T. gondii DHFR developed at U.S. universities

Allelix characterizes first-generation NGF receptor antagonist with antiallodynic properties

Rapamune up for FDA advisory committee review in late July

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...